Align Technology, Inc. vs e l f Beauty Inc — how do they compare? Align Technology, Inc. trades at $171.67 (market cap $12.29B), while e l f Beauty Inc trades at $93.6 (market cap $5.61B). The key difference: Align Technology, Inc. is far larger — about 2.2× e l f Beauty Inc's market cap, and Align Technology, Inc. is trading nearer its 52-week high, e l f Beauty Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | ELF | |
|---|---|---|
Market Cap | $12.29B | $5.61B |
Sector | Health | Technology |
52-Week High | $197.51 | $146.67 |
52-Week Low | $124.88 | $49.57 |
Enterprise Value | $11.30B | $6.19B |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $176.04, up 1.37% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported record Q2 2026 revenue of $1.06 billion, driven by strong clear aligner volume growth. Analyst sentiment is positive, with 73% recommending buy, and institutional activity shows mixed positioning amid strategic initiatives like board changes and patent wins in China.
The outlook remains favorable due to solid fundamentals and international expansion, but risks include competitive pressures in digital dentistry and reliance on North American market stability. Earnings growth and margin improvements are key catalysts, though valuation multiples near five-year lows suggest potential upside if execution continues.
ELF Beauty trades at $93.02, down 2.33% today, but maintains strong momentum with 30 consecutive quarters of sales growth. Recent Q1 2027 earnings beat expectations with $1.75 EPS versus $0.71 expected, driven by Rhode brand performance. Technical indicators show bullish moving averages but overbought RSI levels. The company raised full-year guidance after 36% revenue growth and a $50 million tariff windfall.
Outlook remains positive with robust growth catalysts, though valuation appears stretched at 96.9x P/E. Key risks include reliance on acquisitions for growth and potential margin pressure as tariff benefits normalize. Analyst consensus is balanced with 46% buy ratings and $91.14 price target, suggesting limited near-term upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →